Cannabis Therapeutics and the Future of Neurology

Key Findings:  The inherent polypharmaceutical properties of cannabis botanicals offer distinct advantages over the current single-target pharmaceutical model and portend to revolutionize neurological treatment into a new reality of effective interventional and even preventative treatment.

Type of Study:  Meta-analysis

Study Result:  Positive

Cannabinoids Studied:  Cannabidiol (CBD), Tetrahydrocannabinol (THC), Cannabidiolic Acid (CBD-a), Tetrahydrocannabinolic Acid (THC-a)

Phytocannabinoid Source:  Not Applicable

Form of Administration:  Not Applicable

Terpenes Studied:  ß-Caryophyllene, Limonene, Linalool, Pinene

Receptors Studied:  CB1, CB2, PPAR - Gamma, TRPs

Ligands Studied:  Serotonin

Study Location(s):  Czech Republic

Year of Pub:  2018

Link to study